BridgeMD
Changes in airway cross sectional areas during residual neuromuscular blockade, and after reversal
EU CTIS ID: 2024-519777-19-00
What this study is testing
The differences in retroglossal pharyngeal cross sectional areas (inspiration and exspiration) measured at different train of four TOF values, and changes in these values compared to (initial) retroglossae pharyngeal areas detected before administration of muscle relaxants. Areas are measured in pixels and the rate of reduction of areas is expressed as a percentage.
- Therapeutic use (Phase IV)
A plain-language read of the study's public EU CTIS listing. The study team confirms the details.
Who can take part
You may be able to join if
- Age: 18-65 years; ASA 1-3; BMI 18.5-25 (normal body weight); men/women in equal proportion; duration of surgeries at least ≥ 30 minutes; intervention requiring intratracheal intubation; patients are in a supine position.
You likely can't join if
- drugs affecting neuromuscular function (magnesium, aminoglycosides); difficult airway, expected difficult intubation; pregnancy (pregnancy test for women of childbearing age to rule out pregnancy we finish); breastfeeding; acute surgery; COPD glaucoma
The study team makes the final eligibility decision.
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 65+ years, 18-64 years. The study team makes the final eligibility decision.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from EU CTIS; the study team decides eligibility.